Big names, big com­pa­nies back a cell ther­a­py start­up run by a high-pro­file re­gen­er­a­tive med ex­pert

One of the best known names in re­gen­er­a­tive med­i­cine is launch­ing a new biotech with as­sets and cash com­ing from a range of mar­quee com­pa­nies that in­cludes Cel­gene.

The founder of the War­ren, NJ-based up­start is Robert Hariri, a co-founder at Craig Ven­ter’s Hu­man Longevi­ty. Hariri ran An­thro­ge­n­e­sis when Cel­gene bought it out 15 years ago, then head­ed Cel­gene Cel­lu­lar Ther­a­peu­tics for a pe­ri­od. Along the way he de­vel­oped projects us­ing stem cells de­rived from hu­man pla­cen­tas and inked col­lab­o­ra­tions be­tween some of the key play­ers, in­clud­ing Cel­gene.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.